Portugal, Feb. 17 -- Portugal based PIERRE FABRE MEDICAMENT PORTUG has secured contract from Instituto Portugues De Oncologia De Coimbra Francisco Gentil, Epe for Excl Pierre Fabre - Binimetinib. The value of the contract is worth 20749920 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....